Arrowhead Pharmaceuticals Inc (ARWR) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Arrowhead Pharmaceuticals Inc   (NASDAQ: ARWR)


Arrowhead Pharmaceuticals Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Arrowhead Pharmaceuticals Inc's ROI in the third quarter of 2026?
Arrowhead Pharmaceuticals Inc recorded a cumulative net loss of $-272 million during 12 months ending in the third quarter of 2026, resulting in a negative return on investment (ROI) of -22.56%.

Within the Healthcare sector 76 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from 3287 to 3355.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
III. Quarter		 (Mar 31 2026)
II. Quarter		 (Dec 31 2025)
I. Quarter		 (Sep 30 2025)
IV. Quarter		 (Jun 30 2025)
III. Quarter
Y / Y Investment Change TTM 72.86 % 53.38 % 56.44 % 69.25 % 91.14 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 1,829 1,425 815 756 718
Return On Investment (TTM) -22.56 % -29.28 % 29.36 % 4.07 % -22.83 %
ARWR's Overall Ranking # 3355 # 3287 # 184 # 1331 # 2655
Seq. Investment Change TTM 29.93 % 16.7 % 7.61 % 5.94 % 15.29 %
Seq. Net Income Change TTM - - 675.63 % - -
Net Income (TTM) in Millions -272 -272 234 30 -159

ARWR Company Profile >> Back to ARWR Roi Comparisons >> See Annual ARWR Return On Investment



Return On Investment ARWR's Ranking
Within: No.
Industry # 18
Sector # 77
Overall # 3355

Return On Investment Statistics
High Average Low
28.96 %
-43.74 %
-177.4 %
(Sep 30 2019)   (Sep 30 2013)







Financial Statements
Arrowhead Pharmaceuticals Inc's III. Quarter Investments $ 1,829 Millions ARWR's Balance sheet
Arrowhead Pharmaceuticals Inc's III. Quarter Income $ -179 Millions Quarterly ARWR's Income Statement
ARWR's Income by Division See ARWR's Income by Division


ARWR Annual Return On Investment (Sep 30 2025)
2025		 (Sep 30 2024)
2024		 (Sep 30 2023)
2023		 (Sep 30 2022)
2022		 (Sep 30 2021)
2021
Total Investments in Millions 756 590 303 438 409
Y / Y Investment Growth 28.11 % 94.69 % -30.85 % 7.18 % -11.47 %
Net Income in Millions 30 -610 -209 -176 -141
Y / Y Net Income Growth - - - - -
Annual Return On Investment 3.99 % -103.36 % -69.07 % -40.28 % -34.45 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 3.99 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ARWR's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ARWR's Competitors
Subscribers only: Roi for Arrowhead Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for ARWR's Customers

Other Ratios
ARWR's Roa ARWR's Inventory Turnover Ratio ARWR's Growth Rates ARWR's Dividend Statistics
ARWR's Profitability Ratios ARWR's Asset Turnover Ratio ARWR's Dividend Growth
ARWR's Roe ARWR's Valuation Ratios ARWR's Financial Strength Ratios ARWR's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-26T06:54:28+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.